BioDelivery Sciences is a pharmaceutical company founded in 1997, focusing on innovative pain management and addiction medicine. It utilizes the unique BioErodible MucoAdhesive (BEMA) drug delivery technology to develop new applications of proven therapies, addressing vital unmet medical needs in the Biotechnology, Health Care, and Pharmaceutical industries. The latest significant investment of $60.00M came in the form of a Post-IPO Debt investment on 28 May 2019, with BioPharma Credit as the investor. BioDelivery Sciences is committed to bringing potentially game-changing treatments to the market, either independently or through collaborations with third parties.
Bio Delivery Sciences Intl
Innovative pain management and addiction medicine through proprietary drug delivery technology, addressing vital unmet medical needs.
Founded 1997
12 employees
Post-IPO Debt
Total: $250.70M
Biotechnology, Health Care +2
General Information
Company Name
Bio Delivery Sciences Intl
Founded Year
1997
Founders / Decision Makers
Employees
12
Industries
Biotechnology, Health Care, Life Sciences +1
Funding Stage
Post-IPO Debt
BounceWatch is an independent company data service, not affiliated with Bio Delivery Sciences Intl. To contact Bio Delivery Sciences Intl, visit bdsi.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Bio Delivery Sciences Intl compare?
A PDF of Bio Delivery Sciences Intl and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Bio Delivery Sciences Intl soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Bio Delivery Sciences Intl
Taxonomy: pharmaceutical company, pain management, addiction medicine, drug delivery technology, BioErodible MucoAdhesive (BEMA), medical needs, collaborations, therapy development, commercialization, partnering, unique technology, innovation, medical advancements
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Debt | $60.00M | 1 |
BioPharma Credit
|
28 May 2019 |
| Post IPO Equity | $50.00M | 1 |
|
17 May 2018 |
| Post IPO Debt | Undisclosed | 1 |
|
23 Feb 2017 |
| Post IPO Debt | $20.70M | 1 |
|
01 Jun 2015 |
| Post IPO Equity | $60.00M | 1 |
Federated Kaufmann Fund
|
13 Feb 2014 |
| Post IPO Debt | $20.00M | - |
|
08 Jul 2013 |
| Post IPO Equity | $40.00M | - |
|
28 Nov 2012 |
Bio Delivery Sciences Intl Alternatives & Competitors
View All Alternatives
Bio Delivery Sciences Intl vs
Pioneering pain management with innovative products and advanced abuse prevention technologies
Post-IPO Equity
Biopharma, Biotechnology
Bio Delivery Sciences Intl vs
НоваМедика / NovaMedica
Russia
Russian pharmaceutical company, own R&D center and production facility in Moscow / Российская фармац...
59 employees
Health Care, Pharmaceutical
Bio Delivery Sciences Intl vs
Forte Bio-Pharma is a privately held specialty pharmaceutical company focused on in-licensing, devel...
Post-IPO Debt
16 employees
Biotechnology, Health Care
FAQ About Bio Delivery Sciences Intl
Innovative pain management and addiction medicine through proprietary drug delivery technology, addressing vital unmet medical needs.
Bio Delivery Sciences Intl was founded in 1997.
Bio Delivery Sciences Intl operates in Biotechnology, Health Care, Life Sciences and Pharmaceutical. Its work centres on pharmaceutical company, pain management, addiction medicine and drug delivery technology.
Bio Delivery Sciences Intl has approximately 12 employees.
Bio Delivery Sciences Intl has completed 7 funding rounds, raising a total of $250.70M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Bio Delivery Sciences Intl include QRxPharma, НоваМедика / NovaMedica, MediciNova, Inc., Ception Therapeutics, Inc., AMW GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bio Delivery Sciences Intl and QRxPharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Bio Delivery Sciences Intl, https://bouncewatch.com/company/biodelivery-sciences, updated 13 November 2024. When citing, please name BounceWatch and link this page.
